mechanism

Alpha-Synuclein Pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Alpha-Synuclein Pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

27Connections
3Hypotheses
10Analyses
7Outgoing
20Incoming
2Experiments
15Debates

Summary

Alpha-synuclein pathology represents one of the most critical and intensively studied mechanisms in modern neuroscience, constituting a hallmark of several neurodegenerative diseases collectively termed synucleinopathies[@spillantini2000]. These disorders include Parkinson's disease (PD), dementia w

View on Wiki →

No AI portrait yet

Mechanism Info
NameAlpha-Synuclein Pathology
Key Genes/ProteinsBAG3
Related PathwaysComplement C3/C3Ar Pathway

Wiki Pages (5)

Knowledge base pages for this entity

Canonical Page

Alpha-Synuclein Pathology

mechanism · 5310 words

Fibrinogen and αVβ3 Integrin in Alpha-Synuclein Pathology

mechanism · 1059 words

Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in Parkinson's Disease

mechanism · 1046 words

Enteric Neurons with Alpha-Synuclein Pathology

cell · 659 words

Enteric Neurons with Alpha-Synuclein Pathology

cell · 599 words

Pathway Diagram

flowchart TD
    Alpha_Synuclein_Pathology{{"Alpha-Synuclein Pathology"}}
    Oxidative_Stress["Oxidative Stress"]
    Alpha_Synuclein_Pathology -->|"causes"| Oxidative_Stress
    BAG3(["BAG3"])
    BAG3 -->|"protects against"| Alpha_Synuclein_Pathology
    Chaperone_Expression("Chaperone Expression")
    Alpha_Synuclein_Pathology -->|"correlates with"| Chaperone_Expression
    DNA(["DNA"])
    Alpha_Synuclein_Pathology -->|"causes"| DNA
    Mitochondria("Mitochondria")
    Alpha_Synuclein_Pathology -->|"causes"| Mitochondria
    Complement_C3_C3Ar_Pathway("Complement C3/C3Ar Pathway")
    Complement_C3_C3Ar_Pathway -->|"mediates"| Alpha_Synuclein_Pathology

    style Alpha_Synuclein_Pathology fill:#4a148c,stroke:#4fc3f7,stroke-width:3px,color:#fff

Outgoing (7)

TargetRelationTypeStr
neurodegenerationcausesdisease0.90
Nigrostriatal Dopaminergic Neurodegenerationcausesphenotype0.90
Chaperone Expressioncorrelates_withprocess0.85
vagus nervepropagates viabrain_region0.70
gut barrier dysfunctioncausesprocess0.70

Incoming (20)

SourceRelationTypeStr
gut microbiotaregulatesprocess0.90
BAG3protects_againstprotein0.90
Complement C3/C3Ar Pathwaymediatespathway0.85
IL-22protective_againstprotein0.70
REG3Gregulatesprotein0.70

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
LRRK2 Haploinsufficiency Traps Microglia in Senescence-Like 0.650 Parkinson's disease -
Physiological SCFAs may worsen alpha-synuclein pathology thr 0.550 neurodegeneration Do physiological concentrations of SCFAs
H2S/butyrate imbalance drives enteric alpha-synuclein pathol 0.380 Parkinson's disease -

Mentioning Analyses (10)

Scientific analyses that reference this entity

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-25 | 5 hypotheses Top: 0.530

Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects

neurodegeneration | 2026-04-24 | 6 hypotheses Top: 0.670

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.699

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Single nucleus RNA-seq and ATAC-seq of postmortem PD brain tissue (n=1 gene_expression Parkinson's disease 0.500 0.00 postmortem_human_tissue extracted N/A
Individuals with SNCA pathogenic variants reported painful dystonia, l genetic_association Parkinson's disease 0.500 0.00 human extracted N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (15)

Multi-agent debates referencing this entity

Hypothesis debate: Microbial Inflammasome Priming Prevention

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

closed · Rounds: 4 · Score: 0.54 · 2026-04-25

Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects

closed · Rounds: 4 · Score: 0.63 · 2026-04-24

This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

The abstract mentions that pathological seeds have different characteristics and

closed · Rounds: 4 · Score: 0.65 · 2026-04-21

Related Research

Hypotheses and analyses mentioning Alpha-Synuclein Pathology in their description or question text

No additional research found